Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-10-03
2006-10-03
Weber, Jon (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S008100, C514S013800, C514S017400, C514S009100, C530S300000, C530S395000, C930S020000, C424S093700, C424S278100, C435S041000
Reexamination Certificate
active
07115562
ABSTRACT:
The present invention relates to a method of reducing cell death in a warm-blood animal wherein said cell death associated with a neurodegenerative disorder, an immune disease, a neoplastic disorder, an inflammatory disorder, or a viral disease. The method comprises administering to said animal a therapeutically effective amount of a peptide comprising amino acid sequence: Ser-Val-Asp-Val-Glu-Tyr.
REFERENCES:
patent: 4011142 (1977-03-01), Jacobi et al.
patent: 5286718 (1994-02-01), Elliott et al.
patent: 5917013 (1999-06-01), Rabkin et al.
patent: 6309873 (2001-10-01), Madrazo et al.
patent: 6348567 (2002-02-01), Krystal et al.
patent: 6841532 (2005-01-01), Krystal et al.
patent: WO 94/07992 (1994-04-01), None
Fung et al., “Beneficial Effects of Streptokinase on Left Ventricular Function After Myocardial Reoxygenation and Reperfusion Following Global Ischemia in the Isolated Rabbit Heart,”J. Cardiovasc. Pharmacol.6(3):429-435, 1984.
Gallus, A.S., “The Use of Antithrombotic Drugs in Artery Disease,” Clin. Haematol. 16:509-559, 1986.
Honig, B., “Protein Folding: From the Levinthal Paradox to Structure Prediction,” J. Mol. Biol. 15:509-559, 1986.
Jackson and Tang, “Complete Amino Acid Sequence of Streptokinase and Its Homology with Serine Protease,”Biochemistry21: 6620-6625, 1982.
Krul,Spectrum: Therapy Markets and Emerging Technologies,Decision Resources, Inc., Waltham, Massachusetts, Aug. 18, 1994, “Apoptosis: A New Therapeutic Approach to Cell-Based Disorders.”.
Mickelson et al., “Protection of Myocardial Function and Coronary Vasculature by Streptokinase,”J. Cardiovasc. Pharmol.12(2):186-195, 1988.
Rabkin, “Streptokinase But Not TPA Ameliorates a Cellular Response of Cardiomyocytes To Anoxia and Reoxygenation,”Can. J. Cardiol.7(Suppl. A): p. 80A, Abstract No. 72, 1991.
Varshavasky, A., “The N-end Rule: Functions, Mysteries, Uses,” Proc. Natl. Acad. Sci. U.S.A. 93:12142-12149, 1996.
Krystal Gerald
Rabkin Simon W.
CV Molecular Therapeutics Inc.
Liu Samuel W.
Weber Jon
LandOfFree
Peptides and their use to ameliorate cell death does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides and their use to ameliorate cell death, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides and their use to ameliorate cell death will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3682236